Geneva Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$300K Sell
4,379
-2,409
-35% -$167K 0.01% 605
2017
Q1
$450K Hold
6,788
0.01% 523
2016
Q4
$382K Sell
6,788
-12
-0.2% -$680 0.01% 534
2016
Q3
$434K Sell
6,800
-4,080
-38% -$259K 0.01% 496
2016
Q2
$704K Buy
10,880
+1,346
+14% +$81.5K 0.01% 374
2016
Q1
$557K Buy
9,534
+56
+0.6% +$3.08K 0.01% 411
2015
Q4
$523K Buy
9,478
+5,808
+158% +$333K 0.01% 410
2015
Q3
$202K Sell
3,670
-698
-16% -$38.7K ﹤0.01% 560
2015
Q2
$236K Sell
4,368
-222
-5% -$12.2K ﹤0.01% 573
2015
Q1
$238K Buy
4,590
+330
+8% +$18.3K ﹤0.01% 564
2014
Q4
$230K Buy
+4,260
New +$239K ﹤0.01% 574

Other funds holding BTI

Geneva Advisors's BTI Position: Q2 2017 in Review

Geneva Advisors reduced its British American Tobacco (BTI) stake by 35% in Q2 2017, selling an estimated $167K and leaving 4,379 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #605.

Geneva Advisors first reported a position in BTI in Q4 2014 and has held it in 11 quarters since. The position peaked at $704K in Q2 2016. 332 funds tracked by Wall St. Rank hold BTI as of Q2 2017.

  • Geneva Advisors held 4,379 shares of British American Tobacco worth $300K as of Q2 2017.
  • Geneva Advisors sold 2,409 British American Tobacco shares in Q2 2017, an estimated $167K.
  • British American Tobacco made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #605 holding.
  • Geneva Advisors first reported a position in British American Tobacco in Q4 2014 and has held it in 11 quarters since.
  • Geneva Advisors's British American Tobacco position peaked at $704K in Q2 2016.
  • 332 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.